The use of anticoagulants in patients hospitalised with COVID-19
In this Cochrane Corner, we highlight the main findings of a Cochrane Review by Flumignan et al. entitled ‘Anticoagulants for people hospitalised with COVID‐19’ and discuss the implications of these findings for research and practice in South Africa. In particular, we underscore the need for additio...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
South African Medical Association
2023-07-01
|
| Series: | Southern African Journal of Critical Care |
| Subjects: | |
| Online Access: | https://samajournals.co.za/index.php/sajcc/article/view/450 |
| _version_ | 1797326967527178240 |
|---|---|
| author | N Gloeck A Jaca T Kredo G Calligaro |
| author_facet | N Gloeck A Jaca T Kredo G Calligaro |
| author_sort | N Gloeck |
| collection | DOAJ |
| description | In this Cochrane Corner, we highlight the main findings of a Cochrane Review by Flumignan et al. entitled ‘Anticoagulants for people hospitalised with COVID‐19’ and discuss the implications of these findings for research and practice in South Africa. In particular, we underscore the need for additional, high‐quality, randomised controlled trials comparing different intensities of anticoagulation in patients with COVID‐19 illness. Individuals in the intensive care unit and those hospitalised with another illness who are incidentally found to be infected with SARS‐CoV‐2 should still only be treated with prophylactic‐dose low‐molecular‐weight heparin. |
| first_indexed | 2024-03-08T06:31:44Z |
| format | Article |
| id | doaj.art-da3c8ed694594d828ec8bc9351385bfb |
| institution | Directory Open Access Journal |
| issn | 1562-8264 2078-676X |
| language | English |
| last_indexed | 2024-03-08T06:31:44Z |
| publishDate | 2023-07-01 |
| publisher | South African Medical Association |
| record_format | Article |
| series | Southern African Journal of Critical Care |
| spelling | doaj.art-da3c8ed694594d828ec8bc9351385bfb2024-02-03T11:44:40ZengSouth African Medical AssociationSouthern African Journal of Critical Care1562-82642078-676X2023-07-01545610.7196/SAJCC.2023.v39i2.450454The use of anticoagulants in patients hospitalised with COVID-19N Gloeck0A Jaca1https://orcid.org/0000-0002-9814-8374T Kredo2https://orcid.org/0000-0001-7115-9535G Calligaro3https://orcid.org/0000-0001-7324-0775 Cochrane South Africa, South African Medical Research Council, Parow Valley, South Africa; Health Systems Research Unit, South African Medical Research Council, Parow Valley, South AfricaCochrane South Africa, South African Medical Research Council, Parow Valley, South AfricaCochrane South Africa, South African Medical Research Council, Parow Valley, South Africa; Health Systems Research Unit, South African Medical Research Council, Parow Valley, South AfricaDivision of Pulmonology, Department of Medicine, University of Cape Town, South AfricaIn this Cochrane Corner, we highlight the main findings of a Cochrane Review by Flumignan et al. entitled ‘Anticoagulants for people hospitalised with COVID‐19’ and discuss the implications of these findings for research and practice in South Africa. In particular, we underscore the need for additional, high‐quality, randomised controlled trials comparing different intensities of anticoagulation in patients with COVID‐19 illness. Individuals in the intensive care unit and those hospitalised with another illness who are incidentally found to be infected with SARS‐CoV‐2 should still only be treated with prophylactic‐dose low‐molecular‐weight heparin.https://samajournals.co.za/index.php/sajcc/article/view/450covid-19anticoagulationlow molecular weight heparinsouth africa |
| spellingShingle | N Gloeck A Jaca T Kredo G Calligaro The use of anticoagulants in patients hospitalised with COVID-19 Southern African Journal of Critical Care covid-19 anticoagulation low molecular weight heparin south africa |
| title | The use of anticoagulants in patients hospitalised with COVID-19 |
| title_full | The use of anticoagulants in patients hospitalised with COVID-19 |
| title_fullStr | The use of anticoagulants in patients hospitalised with COVID-19 |
| title_full_unstemmed | The use of anticoagulants in patients hospitalised with COVID-19 |
| title_short | The use of anticoagulants in patients hospitalised with COVID-19 |
| title_sort | use of anticoagulants in patients hospitalised with covid 19 |
| topic | covid-19 anticoagulation low molecular weight heparin south africa |
| url | https://samajournals.co.za/index.php/sajcc/article/view/450 |
| work_keys_str_mv | AT ngloeck theuseofanticoagulantsinpatientshospitalisedwithcovid19 AT ajaca theuseofanticoagulantsinpatientshospitalisedwithcovid19 AT tkredo theuseofanticoagulantsinpatientshospitalisedwithcovid19 AT gcalligaro theuseofanticoagulantsinpatientshospitalisedwithcovid19 AT ngloeck useofanticoagulantsinpatientshospitalisedwithcovid19 AT ajaca useofanticoagulantsinpatientshospitalisedwithcovid19 AT tkredo useofanticoagulantsinpatientshospitalisedwithcovid19 AT gcalligaro useofanticoagulantsinpatientshospitalisedwithcovid19 |